Intrinsic Value of S&P & Nasdaq Contact Us

Cytokinetics, Incorporated CYTK NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$92.27
+41.2%

Cytokinetics, Incorporated (CYTK) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, ARVN, BDTX, BPMC, DICE and others.

CYTK has a market capitalization of $8.05B, compared to an average peer market cap of $2.98B. CYTK is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message